In the strong group, characterized by worse outcomes, CD8+ cells could be involved in the activation of tumor immune evasion processes because CD8+ cells promote the secretion of prostaglandin E2 which consequently induces tumor escape via the Fas signaling pathway [40,41]. The gene discussed is CD8A; the disease is neoplasm.